RIM
BIIB icon

Reliant Investment Management’s Biogen BIIB Stock Holding History

Reliant Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-8,000
Closed -$2.45M – 61
2015
Q4 		$2.45M Buy
8,000
+110
+1% +$31.6K 2.13% 30
2015
Q3 		$2.3M Buy
7,890
+856
+12% +$283K 2.26% 26
2015
Q2 		$2.84M Buy
7,034
+45
+0.6% +$18.1K 2.59% 13
2015
Q1 		$2.95M Hold
6,989
– – 2.64% 14
2014
Q4 		$2.37M Sell
6,989
-168
-2% -$54.4K 2.14% 23
2014
Q3 		$2.37M Buy
7,157
+310
+5% +$102K 2.2% 24
2014
Q2 		$2.16M Buy
+6,847
New +$2.06M 1.97% 30

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Reliant Investment Management's BIIB Position: Q1 2016 in Review

Reliant Investment Management sold out of Biogen (BIIB) in Q1 2016, closing a stake of 8,000 shares — an estimated $2.45M sold.

Reliant Investment Management first reported a position in BIIB in Q2 2014 and held it in 7 quarters. The position peaked at $2.95M in Q1 2015. 948 funds tracked by Wall St. Rank hold BIIB as of Q1 2016.

  • Reliant Investment Management reported no remaining Biogen position as of Q1 2016 after selling out during the quarter.
  • Reliant Investment Management sold 8,000 Biogen shares in Q1 2016, an estimated $2.45M.
  • Reliant Investment Management first reported a position in Biogen in Q2 2014 and held it in 7 quarters.
  • Reliant Investment Management's Biogen position peaked at $2.95M in Q1 2015.
  • 948 funds tracked by Wall St. Rank held Biogen as of Q1 2016.

Based on Reliant Investment Management's 13F filing for Q1 2016, filed 13 May 2016.